Dr. Reddy's Labs Appoints Global Head of Biologics and Deloitte Haskins & Sells as Independent Auditor
Dr. Reddy's Laboratories Limited has announced significant executive appointments and confirmed the selection of its Independent Registered Public Accounting Firm. The Board approved the appointment of Dr. Sridevi Khambhampaty as Global Head of Biologics, effective July 22, 2026. Additionally, M/s Deloitte Haskins & Sells, LLP was appointed to serve as the company's Independent Registered Public Accounting Firm for a term spanning five consecutive years.In addition to Dr. Khambhampaty’s appointment, the Board of Directors confirmed key leadership roles and updated the list of Senior Management Personnel (SMP).
Key Appointments Details
The Board meeting held on July 22, 2026, approved the induction of Dr. Sridevi Khambhampaty as a Member of the Management Council in her new capacity.Details regarding Dr. Sridevi Khambhampaty's appointment include:
| Sl.no | Particulars | Details |
|---|---|---|
| 1. | Reason for change viz. appointment, re-appointment, resignation, removal, death or otherwise | Appointment of Dr. Sridevi Khambhampaty as Global Head of Biologics and Senior Management Personnel of the Company, and her induction as a Member of the Management Council |
| 2. | Date of appointment/re- appointment/cessation (as applicable) & term of appointment/re- appointment | July 22, 2026 |
| 3. | Brief profile (in case of appointment) | As mentioned below |
Dr. Khambhampaty holds a PhD in Biological Sciences from NCBS (TIFR) and completed her postdoctoral research at Stanford University School of Medicine. She is described as an accomplished biopharmaceutical leader with over two decades of experience spanning Biologics R&D, Quality, and Business leadership. Prior to joining Dr. Reddy's, she held senior leadership roles at Syngene International and Intas Biopharma and served as the CEO of Shilpa Biologics. She brings deep expertise in biologics, development strategy, regulatory sciences, and cross-functional leadership.
Auditor Appointment Confirmed
The company confirmed that M/s Deloitte Haskins & Sells, LLP has been appointed as the Independent Registered Public Accounting Firm. This appointment is intended for auditing the financial statements of the Company to be included in the Annual Report on Form 20-F and reviewing interim financial statements to be filed with the U.S. Securities and Exchange Commission on Form 6-K.The appointment details for M/s Deloitte Haskins & Sells, LLP are as follows:
| Sl.no | Particulars | Details |
|---|---|---|
| 1. | Reason for change viz. appointment, re- appointment, resignation, removal, death or otherwise | Appointment |
| 2. | Date of appointment/re- appointment/cessation (as applicable) & term of appointment/re- appointment | July 22, 2026 |
| 3. | Brief profile (in case of appointment) | Deloitte Haskins & Sells, Mumbai was constituted in 1997 and has been converted to a Limited Liability Partnership (LLP), with the name Deloitte Haskins & Sells LLP ("'DHS LLP'" or "'Firm'"), w.e.f. November 20, 2013. DHS LLP is registered with the Institute of Chartered Accountants of India (Registration No. 117366W/W-100018) and is a part of Deloitte Haskins & Sells & Affiliates being the Network of Firms registered with the ICAI. |
Senior Management Personnel List
The updated list of Dr. Reddy's Laboratories Limited's Senior Management Personnel (SMP) includes:| Sl.No | Name of the SMP | Designation |
|---|---|---|
| 1 | Mr. Satish Reddy | Chairman and Whole-time Director |
| 2 | Mr. G V Prasad | Co-Chairman and Managing Director (KMP) |
| 3 | Mr. Erez Israeli | Chief Executive Officer (KMP) |
| 4 | Mr. M V Ramana | CEO Global Generics |
| 5 | Mr. Sanjay Sharma | Chief Operating Officer |
| 6 | Mr. M V Narasimham | Chief Financial Officer (KMP) |
| 7 | Mr. Deepak Sapra | Chief Executive Officer, API and Services |
| 8 | Mr. Krishna Venkatesh | Global Head of IPDO - Integrated Product Development Organization |
| 9 | Mr. Patrick Aghanian | Head - Consumer Health Organization |
| 10 | Mr. Phanimitra B | Chief Digital and Information Officer |
| 11 | Mr. Milan Kalawadia | Chief Executive Officer, North America |
| 12 | Mr. M S Madhu Sundar | Global Head of Quality and PV |
| 13 | Mr. Sandeep Khandelwal | Global Generics India Head |
| 14 | Dr. Sridevi Khambhampaty | Global Head of Biologics |
| 15 | Mr. K Randhir Singh | Company Secretary, Compliance Officer and Head-CSR (KMP) |
DRREDDY Stock Price Movement
Shares of Dr. Reddy's Laboratories Limited on Wednesday slipped by 2.16% to settle at ₹1182.8, falling ₹26.10 from the previous day's close. The stock traded with a volume of 2.53 million shares, reflecting the decline in pharmaceutical equities.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.